{
  "id": "06aca9ec8dfdf85a",
  "title": "FDA faces brain drain as 4th director exits role",
  "description": "Another abrupt departure of a high ranking Food and Drug Administration (FDA) official is raising alarm about a brain drain that could mean new drugs take longer to reach the public. The stakes are enormous for both pharmaceutical companies spending huge sums\u2026",
  "content": "Another abrupt departure of a high ranking Food and Drug Administration (FDA) official is raising alarm about a brain drain that could mean new drugs take longer to reach the public. The stakes are e\u2026 [+4443 chars]",
  "source": "Rolling Out",
  "source_url": "https://rollingout.com/2025/12/04/fda-4th-director-exits-role/",
  "published_at": "2025-12-04T14:51:03Z",
  "fetched_at": "2025-12-06T18:33:06.472112+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "brain drain",
    "ai",
    "drug",
    "search:drug approval FDA breakthrough"
  ],
  "location": null,
  "raw_data": {
    "source": {
      "id": null,
      "name": "Rolling Out"
    },
    "author": "Vera Emoghene",
    "title": "FDA faces brain drain as 4th director exits role",
    "description": "Another abrupt departure of a high ranking Food and Drug Administration (FDA) official is raising alarm about a brain drain that could mean new drugs take longer to reach the public. The stakes are enormous for both pharmaceutical companies spending huge sums\u2026",
    "url": "https://rollingout.com/2025/12/04/fda-4th-director-exits-role/",
    "urlToImage": "https://rollingout.com/wp-content/uploads/2025/11/shutterstock_2606687947-scaled.jpg",
    "publishedAt": "2025-12-04T14:51:03Z",
    "content": "Another abrupt departure of a high ranking Food and Drug Administration (FDA) official is raising alarm about a brain drain that could mean new drugs take longer to reach the public. The stakes are e\u2026 [+4443 chars]"
  }
}